iiinova — where your digital self keeps evolving

Reposted by Sirus Jesudasen, MD

International Society for Heart and Lung Transplantation (ISHLT) @ishlt.bsky.social · 15/05/2025

📣 The 2024 report from the #ISHLT International #Thoracic Organ #Transplant Registry is now available online to members. This official relaunch of the registry includes new data from 12 global partners covering heart/lung transplantations 1992-2024. Download the report here: bit.ly/3FaIkzo

#ISHLT #TTX Registry Chair Rebecca Cogswell addresses the audience at #ISHLT2025

121

Sirus Jesudasen, MD @sirusjj.bsky.social · 30/04/2025

What an amazing showing by the MGH Lung Transplant program at #ISHLT2025! Proud to be contributing to Lung Transplant science with session moderation, oral presentations, posters, and connecting with colleagues from across the world #MGH #LungTxp #Transplantsky #Pulmsky #ISHLT @mgh-id.bsky.social

171

Reposted by Sirus Jesudasen, MD

Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · 29/04/2025

How to define AMR and ACR in #lungtransplantation ? Standing room only at #ISHLT Acute Lung Allograft Dysfunction suggests that many share this question ! @ishlt.bsky.social #transplantresearch

153

Sirus Jesudasen, MD @sirusjj.bsky.social · 30/04/2025

Wrapping up the final session at #ISHLT2025, we will lastly hear on outcomes in specific and complex patient populations. Highlights from the oral session on Lung Transplant Outcomes 🫁♻️: Considerations for Specific Patient Populations 🧩! #Transplantsky #LungTxp #Pulmsky

110

Sirus Jesudasen, MD @sirusjj.bsky.social · 30/04/2025

Next up at #ISHLT2025: Exploring DCD donors 🫀 - how we navigate uncertainty, decision making, & challenges. Discover how DCD offers a vital chance 🎲 to many patients waiting for lung transplant 🫁♻️. #Transplantsky #LungTxp #Pulmsky

121

Sirus Jesudasen, MD @sirusjj.bsky.social · 30/04/2025

To start our final day of #ISHLT2025, we are ready to explore donor lung 🫁 allocation focusing on the present CAS era 🕰️. Highlights ✨ from the #ISHLT2025 oral session on Donor Lung Allocation with CAS and Beyond! #Transplantsky #LungTxp #Pulmsky

111

Sirus Jesudasen, MD @sirusjj.bsky.social · 29/04/2025

Rounding out the day, with lung transplant 🫁♻️ in particular we have to fight off all sorts of infections 🦠👾🥊. Highlights ✨ from the #ISHLT2025 oral session on Treating #LungTxp Infections: #TxID #Pulmsky #Transplantsky

110

Sirus Jesudasen, MD @sirusjj.bsky.social · 29/04/2025

Between sick patients 🤒 pre-transplant, hemodynamic support intra-OR 🔪, and bridging support after #LungTxp 🌉, ECLS and #ECMO are critical modern tools 🛠️. Very appreciative for perspectives at #ISHLT2025 on how to best plan & manage these systems for our 🫁♻️ pts as follows: #transplantsky #pulmsky

100

Sirus Jesudasen, MD @sirusjj.bsky.social · 29/04/2025

Small ideas 💡 in the OR can lead to giant leaps 🐾 in what we provide for our lung transplant patients 🫁♻️: Excited to learn about operative advances in #LungTxp through this Symposium at #ISHLT2025! #Transplantsky #Transplant

100

Sirus Jesudasen, MD @sirusjj.bsky.social · 28/04/2025

With our new 🫁 now successfully transplanted ♻️, we may transition to outcomes after #LungTxp, and how different risk factors or scenarios may effect patient outcomes in the short-term and/or extending into future years 📆. Read on for a rapid fire series ✨🔥 on txp outcomes at #ISHLT2025 !

110

Sirus Jesudasen, MD @sirusjj.bsky.social · 28/04/2025

With our patients optimized for new 🫁, our focus shifts to novel ways to improve the donor 🫁 and take #LungTxp 🫁♻️ to the next level 🚀. Ready to hear at #ISHLT2025 how we emerging technology and EVLP can optimize 🫁 for edema 💦, infection 🦠, rejection ❌, and more! #TxID #Transplantsky #Pulmsky

110

Sirus Jesudasen, MD @sirusjj.bsky.social · 28/04/2025

When it comes to #LungTxp 🫁♻️, nothing is possible without determining the right transplant candidates ✅ and giving them the best chance 🎲 for success. Ready to learn on day 2 of #ISHLT2025 about how to tackle candidate selection & optimizing them for the big day! #transplantsky #pulmsky #TxID

100

Sirus Jesudasen, MD @sirusjj.bsky.social · 27/04/2025

So many tools 🛠️ to optimize donor lungs 🫁 as we use them for our transplant ♻️ candidates. Intrigued how different techniques, technologies, and donor selection may give our patients the best chance at success. 👌 moderation by Dr. Benden (Boston Children's) at #ISHLT2025! #LungTransplant #EVLP

110

Sirus Jesudasen, MD @sirusjj.bsky.social · 27/04/2025

Ideal preservation ❄️ of lungs 🫁 is critical for successful lung txp ♻️. Excited to hear how 🫁 perform across different ❄️ strategies and EVLP 🤖📦. Appreciate the stellar moderation by Dr. Cantu (UPenn) and Dr. Schwarz (Vienna) at #ISHLT2025! #LungTransplant #EVLP

111

Sirus Jesudasen, MD @sirusjj.bsky.social · 27/04/2025

One of the first sessions of #ISHLT2025: How to think about telomere biology disorders 🧬 when evaluating patients for lung transplantation! Read on for when — and why — to consider telomere issues in lung transplant candidates. #LungTransplant #TransplantResearch

141

Sirus Jesudasen, MD @sirusjj.bsky.social · 27/04/2025

Fantastic opening session at #ISHLT2025 this morning! New 🫁♻️ #LungTransplant data from the ISHLT Registry now available today (ishltregistries.org/registries/s...) — new data since 2018 with improving 1-year survival. Excited for more cutting-edge science this week! #TransplantResearch

121

Sirus Jesudasen, MD @sirusjj.bsky.social · 26/04/2025

Pumped for #ISHLT2025 to kick off shortly in Boston! Get ready for some game-changing updates in how we manage lung transplantation 🫁♻️. I’ll be posting highlights all week—stay tuned! @ishlt.bsky.social

121